Can I read Gilead - RDV Development Fact Sheet 2020 on EtoBox?

Gilead - RDV Development Fact Sheet 2020 by Himanshi Dahiya is a document available to read on EtoBox.

What is Gilead - RDV Development Fact Sheet 2020 about?

Remdesivir was developed by Gilead over a decade of research into antiviral compounds. It showed promise in preclinical studies against Ebola, SARS, MERS and most recently COVID-19. Gilead is now supporting multiple clinical trials of remdesivir to evaluate its safety and efficacy in treating COVID-19.

Author

Himanshi Dahiya

Language

EN